Literature DB >> 8723388

Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.

A Gatignol1, M Duarte, L Daviet, Y N Chang, K T Jeang.   

Abstract

The regulation of HIV expression is controlled by the activity of the Long Terminal Repeat (LTR). Trans-activation by the virally encoded Tat protein is one of the main mechanisms of LTR activation. Tat binds to its target, TAR RNA, and cellular proteins that bind the LTR, Tat, or TAR RNA are important components of the trans-activation process. We will review the factors that have been characterized for a possible involvement in this mechanism. Whereas LTR binding proteins consist of Sp1 and TBP, a large number of factors that bind TAR RNA have been isolated. We have previously cloned two of them by RNA probe recognition: TRBP and La. We have shown that the in vitro and in vivo binding of TRBP to TAR RNA correlates with a constant expression of the protein during HIV-1 infection. Several proteins that interact with Tat have mainly positive, but some negative, effects on trans-activation. Genetic studies have defined that human chromosome 12 encodes a protein that will allow trans-activation in rodent cells. The binding and the functional data about these proteins suggest sequential steps for the Tat trans-activation mechanism. Each of these intracellular molecular events could be the target for molecular intervention against the virus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723388      PMCID: PMC6138028     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  77 in total

1.  tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.

Authors:  F Wu; J Garcia; D Sigman; R Gaynor
Journal:  Genes Dev       Date:  1991-11       Impact factor: 11.361

2.  Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  B Berkhout; K T Jeang
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Synthesis of functional human immunodeficiency virus tat protein in baculovirus as determined by a cell-cell fusion assay.

Authors:  K T Jeang; P R Shank; A B Rabson; A Kumar
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes.

Authors:  B Ohana; P A Moore; S M Ruben; C D Southgate; M R Green; C A Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

Review 6.  Control of RNA initiation and elongation at the HIV-1 promoter.

Authors:  K A Jones; B M Peterlin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

7.  trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis.

Authors:  B Berkhout; K T Jeang
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells.

Authors:  A Alonso; D Derse; B M Peterlin
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

9.  Direct interaction of human TFIID with the HIV-1 transactivator tat.

Authors:  F Kashanchi; G Piras; M F Radonovich; J F Duvall; A Fattaey; C M Chiang; R G Roeder; J N Brady
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

10.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

Authors:  E Verdin; P Paras; C Van Lint
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  15 in total

1.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 2.  Protein interactions and complexes in human microRNA biogenesis and function.

Authors:  Marjorie P Perron; Patrick Provost
Journal:  Front Biosci       Date:  2008-01-01

3.  Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer.

Authors:  Xiaoti Lin; Minqing Wu; Peng Liu; Fengqin Wei; Laisheng Li; Hailin Tang; Xinhua Xie; Xiaoping Liu; Lu Yang; Xiaoming Xie
Journal:  Med Oncol       Date:  2014-02-22       Impact factor: 3.064

Review 4.  The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer.

Authors:  Sylvanne M Daniels; Anne Gatignol
Journal:  Microbiol Mol Biol Rev       Date:  2012-09       Impact factor: 11.056

5.  Characterization of the TRBP domain required for dicer interaction and function in RNA interference.

Authors:  Sylvanne M Daniels; Carlos E Melendez-Peña; Robert J Scarborough; Aïcha Daher; Helen S Christensen; Mohamed El Far; Damian F J Purcell; Sébastien Lainé; Anne Gatignol
Journal:  BMC Mol Biol       Date:  2009-05-07       Impact factor: 2.946

6.  HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.

Authors:  Sebastian Eilebrecht; Emmanuelle Wilhelm; Bernd-Joachim Benecke; Brendan Bell; Arndt G Benecke
Journal:  RNA Biol       Date:  2013-02-07       Impact factor: 4.652

7.  TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress.

Authors:  Aïcha Daher; Ghislaine Laraki; Madhurima Singh; Carlos E Melendez-Peña; Sylvie Bannwarth; Antoine H F M Peters; Eliane F Meurs; Robert E Braun; Rekha C Patel; Anne Gatignol
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

8.  Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.

Authors:  Helen S Christensen; Aïcha Daher; Kaitlin J Soye; Lisa B Frankel; Marina R Alexander; Sébastien Lainé; Sylvie Bannwarth; Chi L Ong; Sean W L Chung; Shahan M Campbell; Damian F J Purcell; Anne Gatignol
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

9.  Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.

Authors:  Leonie A Boven; Farshid Noorbakhsh; Gerben Bouma; Ruurd van der Zee; Diana L Vargas; Carlos Pardo; Justin C McArthur; Hans S L M Nottet; Christopher Power
Journal:  J Neurovirol       Date:  2007-04       Impact factor: 2.643

Review 10.  Protein components of the microRNA pathway and human diseases.

Authors:  Marjorie P Perron; Patrick Provost
Journal:  Methods Mol Biol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.